CTEV

Dalton Travis

Known title: Pres., CEO & Executive ChairCIK: 0001841409

Dalton Travis's purchase track record

How the stock did after each of Dalton Travis's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
6
of 8 since August 7, 2024
Stock higher 6 months later
67%
3 months: 71%
Median 6-month return
+72.5%
3 months: +86.5%
Beat the S&P 500
67%
median +57.3% vs. index
PurchaseStockAmount3 months6 months
8/27/2026CTEV$250Kpendingpending
5/18/2026CTEV$259K+115.3%pending
2/27/2026CTEV$200K+86.5%+192.4%
11/20/2025CTEV$250K-48.5%-47.9%
8/8/2025CTEV$248K+21.9%-54.4%
5/15/2025CTEV$100K+147.9%+61.6%
3/7/2025CTEV$101K+116.7%+282.4%
8/7/2024CTEV$185K-27.0%+83.3%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 25, 2026

Claritev Selected by GDIT for WTC Health Program Support. Claritev has been selected by General Dynamics Information Technology (GDIT) to support the World Trade Center Health Program. The financial terms of this agreement were not disclosed. This development adds a notable government-related contract to the company's portfolio, which is relevant context given the stock is currently trading near its 52-week low.

this person other insiders at CTEV

Transaction History

CTEV▲ Buy$75K
CTEV▲ Buy$175K
CTEV▲ Buy$126K
CTEV▲ Buy$133K
CTEV▼ Sell$132K
CTEV▲ Buy$0
CTEV▼ Sell$186K
CTEV▲ Buy$200K
CTEV▲ Buy$250K
CTEV▲ Buy$232K
CTEV▲ Buy$16K
CTEV▲ Buy$100K
CTEV▲ Buy$101K
CTEV▼ Sell$384K
CTEV▲ Buy$0
CTEV▲ Buy$185K
CTEV▲ Buy$5.0M

We use analytics to understand how market-wall is used. No personal data is sold.